SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-018943
Filing Date
2021-08-09
Accepted
2021-08-06 17:37:56
Documents
12
Period of Report
2021-08-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38091
  Complete submission text file 0001493152-21-018943.txt   208999

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE indp-20210803.xsd EX-101.SCH 3030
3 XBRL LABEL FILE indp-20210803_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE indp-20210803_pre.xml EX-101.PRE 22362
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3454
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 211154010
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences